Medical Research · NY
Global Alliance For Tb Drug Development Inc
Global Alliance For Tb Drug Development Inc reported paying Dr Melvin Spigelman, President/ceo, $1,028,783 in total compensation (FY 2023).
That places Dr Melvin Spigelman at approximately the 100th percentile among 15 similarly sized medical research nonprofits (median $408,637).
$60,240,486Total revenue (FY 2023)
$1,028,783Total executive compensation
100thPercentile vs. peers
Setting executive pay for this board?
Generate a board-ready comparability report for Global Alliance For Tb Drug Development Inc — named comparables, percentiles, methodology, and the 26 CFR 53.4958-6 minutes language a board can use toward the rebuttable presumption.
Build the comparability report →Comparable medical research nonprofits
Compensation is normalized to NY cost of living (BEA Regional Price Parities); each organization's reported figure is on its linked 990.
| Organization | State | Revenue | Total comp |
|---|---|---|---|
| Philadelphia Fight | PA | $60,617,671 | $408,637 |
| Foundation For The National Institutes Of Health Inc | MD | $60,965,788 | $679,772 |
| The V Foundation | NC | $62,401,014 | $276,219 |
| Dean Mcgee Eye Institute | OK | $57,365,664 | $166,416 |
| Stanley Manne Childrens Research Institute | IL | $63,149,782 | $667,521 |
| Hennepin Healthcare Research Institute | MN | $54,717,221 | $334,669 |
| Every Cure Inc | PA | $54,466,208 | $499,013 |
| The Gog Foundation Inc | MD | $66,124,814 | $352,562 |